UK markets close in 6 hours 1 minute

Galmed Pharmaceuticals Ltd (GPH.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.28000.0000 (0.00%)
As of 08:10AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
3,569
3,569
12,995
27,220
26,082
Selling general and administrative
3,923
3,923
4,656
5,661
4,128
Total operating expenses
7,492
7,492
17,651
32,881
30,210
Operating income or loss
-7,492
-7,492
-17,651
-32,881
-30,210
Total other income/expenses net
216
216
-490
-105
278
Income before tax
-6,912
-6,912
-17,866
-32,467
-28,771
Income tax expense
-
-
-
-
0
Income from continuing operations
-6,912
-6,912
-17,866
-32,467
-28,771
Net income
-6,912
-6,912
-17,866
-32,467
-28,771
Net income available to common shareholders
-6,912
-6,912
-17,866
-32,467
-28,771
Basic EPS
-3.02
-2.50
-10.65
-19.80
-20.25
Diluted EPS
-3.02
-2.50
-10.65
-19.80
-20.25
Basic average shares
2,832
2,770
1,676
1,640
1,419
Diluted average shares
2,832
2,770
1,676
1,640
1,419